GLENMARK PHARMS LTD FDA Approval ANDA 212317

ANDA 212317

GLENMARK PHARMS LTD

FDA Drug Application

Application #212317

Documents

Letter2021-04-13

Application Sponsors

ANDA 212317GLENMARK PHARMS LTD

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001CAPSULE, EXTENDED RELEASE;ORAL60MG0DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDE
002CAPSULE, EXTENDED RELEASE;ORAL90MG0DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDE
003CAPSULE, EXTENDED RELEASE;ORAL120MG0DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2021-03-22STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB1
002PrescriptionAB1
003PrescriptionAB1

CDER Filings

GLENMARK PHARMS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212317
            [companyName] => GLENMARK PHARMS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"DILTIAZEM HYDROCHLORIDE","activeIngredients":"DILTIAZEM HYDROCHLORIDE","strength":"60MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"DILTIAZEM HYDROCHLORIDE","activeIngredients":"DILTIAZEM HYDROCHLORIDE","strength":"90MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"DILTIAZEM HYDROCHLORIDE","activeIngredients":"DILTIAZEM HYDROCHLORIDE","strength":"120MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/22\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-03-22
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.